1-1 of 1
Marie DelFavero, BSN, RN, CCRP
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I/II Study of Escalating Doses of Thalidomide (Thal) in Conjunction with Bortezomib (Vel) and High Dose Melphalan (Mel) As A Conditioning Regimen for Autologous Peripheral Blood Stem Cell Transplantation (PBSCT) in Patients with Advanced Multiple Myeloma (MM).

Sung H Hong, David S Siegel, MD, PhD., Michele L Donato, MD, David H. Vesole, MD, PhD, Andrew L Pecora, MD, Joshua R. Richter, MD, Emily Brown, BSN, RN, CHPN, Kathryn Buttner, BSN, RN, OCN, Marie DelFavero, BSN, RN, CCRP, Daniel Kim, Andrea Ortega, BA, CCRP, Scott D Rowley, MD
Journal: Blood
Blood (2012) 120 (21): 3104.
https://doi.org/10.1182/blood.V120.21.3104.3104
Published: 2012